Ovarian cancer vignettes: guideline adherence and definitive action
| UK | Europe | Canada | Australia | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Wales | Northern Ireland | England | Denmark | Norway | Sweden | Manitoba | Ontario | New South Wales | Victoria | |
| 1-year ovarian cancer survival, % | 60.5 | 63.9 | 65.4 | 70.6 | 75.2 | Not available | 68 | 75.9 | 73.3 | 73.7 |
| Vignette 5 summary: 53-year-old female, LMP 6 months ago, R colicky lower abdominal pain for 3 weeks, no change in bowel habit (PPV 0.3%) | ||||||||||
| Definitive action taken by clinician, % | 39 | 38 | 37 | 42 | 44 | 53 | 59 | 73 | 62 | 65 |
| % (95% CI) | 38 (32 to 34) | 61 (58 to 64)a | ||||||||
| Action recommended by guideline | NDG | NDG | NDG | NDG | No guideline | No guideline | No guideline | No guideline | No guideline | No guideline |
↵a P<0.05 for difference between UK and non-UK jurisdictions.
LMP = last menstrual period. NDG = not defined in guideline. PPV = positive predictive value.